Neuraxis NRXS
NYSE NRXS
$6.15 -0.12 (-1.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neuraxis (NRXS) Free Cash Flow (2022 - 2025)

Neuraxis (NRXS) posted Free Cash Flow of -$1.9 million for Q4 2025, down 35.9% sequentially from -$1.4 million in Q3 2025, and down 10.34% YoY from -$2.2 million in Q4 2024.

Neuraxis (NRXS) Free Cash Flow (2022 - 2025) Analysis & Trends

Neuraxis has reported Free Cash Flow for 4 years, with the latest figure at -$1.9 million in Q4 2025.

  • Quarterly Free Cash Flow fell 10.34% year-over-year to -$1.9 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$4.8 million (up 24.35% YoY) and the FY2025 annual result came in at -$6.5 million, down 5.52% from the prior year.
  • Free Cash Flow slipped to -$1.9 million in Q4 2025 per NRXS's latest filing, from -$1.4 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$204315.0 in Q4 2022 and troughed at -$2.8 million in Q3 2023.
  • A 4-year average of -$1.5 million and a median of -$1.5 million in 2025 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2023 and 2024: Free Cash Flow sank 1194.86% in 2023, then surged 50.44% in 2024.
  • Over 4 years, Free Cash Flow stood at -$204315.0 in 2022, then tumbled by 1194.86% to -$2.6 million in 2023, then surged by 33.54% to -$1.8 million in 2024, then declined by 10.34% to -$1.9 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$1.9 million, -$1.4 million, and -$1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -563.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 437.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 292.04 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 433.84 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -95.09 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 477.44 Mn
10 Neuraxis 74.54 Mn 66.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.94 Mn
Dec 31, 2025 -1.94 Mn
Sep 30, 2025 -1.43 Mn
Sep 30, 2025 -1.43 Mn
Jun 30, 2025 -1.47 Mn
Jun 30, 2025 -1.47 Mn
Mar 31, 2025 -1.62 Mn
Mar 31, 2025 -1.62 Mn
Dec 31, 2024 -1.76 Mn
Dec 31, 2024 -1.76 Mn
Sep 30, 2024 -1.40 Mn
Sep 30, 2024 -1.40 Mn
Jun 30, 2024 -1.62 Mn
Jun 30, 2024 -1.62 Mn
Mar 31, 2024 -1.35 Mn
Mar 31, 2024 -1.35 Mn
Dec 31, 2023 -2.65 Mn
Dec 31, 2023 -2.65 Mn
Sep 30, 2023 -2.82 Mn
Sep 30, 2023 -2.82 Mn